TC BioPharm (Holdings) Plc (TCBP): Total Asset Value of Company
The price chart of total assets for TC Biopharm (TCBP), valued at 0.00, illustrates the resources of the company developing cancer treatments via T-lymphocyte modification. The business currently relies on seeking investments to develop allogeneic products, as a stable cash flow has not yet been established. However, steady demand for medications is offset by the risks of supply chain disruptions and the complexities of foreign licensing.
Comprehensive metric breakdowns and analytics for TC BioPharm (Holdings) PLC (TCBP)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental valuation:TCBP, tcbiopharm.com
Assessing the operational strength of TC Biopharm (TCBP) through the total value of resources, including the cryogenic logistics infrastructure for immunopreparation delivery, allows for a determination of business resilience. By analyzing the changes in the company's financial assets, reverse-engineered via ROA, an investor can identify the sum of equity and liabilities, which, amid Fed rate volatility, serves as an indicator of the issuer's real asset value and credit burden.
Competitors of TC Biopharm (TCBP)
ARGX (argenx.com) - Total Asset Value of Company|Aggregate Company Assets BioNTech BNTX|Total Asset Value of Company Abivax|ADMA Bio (ADMA) - Company Total Assets|Aggregate Asset Value Protagonist Corp (PTGX)|Company Total Assets IMVT (Immunovant, Inc.)|kiniksa.com - Company Total Assets|Aggregate Company Assets Grifols (GRFS)|ADPT: Aggregate Asset Value|CLDX (Celldex) - Aggregate Company Assets|Aurinia Corp (AUPH) - Cumulative Company Assets|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com (VERA)|Dianthus Therapeutics, Inc. (DNTH) - Cumulative Company Assets|Aggregate Asset Value Pharvaris NV (PHVS)|Company Total Assets ABCL|Tourmaline - Company Total Asset Base|PGEN: Aggregate Company Assets|PHAR: Cumulative Company Assets|NKTR (Nektar Therapeutics Inc.) - Aggregate Company Assets|Cumulative Company Assets Upstream Bio, Inc.|ZBIO (Zenas Biopharma, Inc.) - Cumulative Company Assets|Company Total Assets IMNM|Aggregate Company Assets Gossamer Bio, Inc. GOSS|Total Business Assets kalvista.com (KALV)|SEPN: Company Total Assets|PVLA - Company Assets|Cumulative Company Assets Savara Corp SVRA|RIGL - Aggregate Business Assets|ANAB (AnaptysBio, Inc.) - Company Total Assets|Cumulative Company Assets astriatx.com|ENGN - Cumulative Company Assets|Aggregate Asset Value RAPT Therapeutics Inc.|Company Total Assets Aerovate Therapeutics Inc (JBIO)|Aggregate Company Assets Aclaris Therapeutics, Inc (ACRS)|Company Total Assets KYTX|tizianalifesciences.com - Company Total Asset Base|CABA (Cabaletta Bio) - Aggregate Company Assets|VTYX: Company Assets|Aggregate Company Assets Theratechnologies Inc (THTX)|Avalo Therapeutics Inc (AVTX) - Total Asset Value of Company|ELDN - Company Total Assets|Aggregate Asset Value agenusbio.com|Company Total Assets CLYM|Company Total Assets ZURA (Zura Bio Ltd)|Aggregate Company Assets aTyr|Adagene Inc - Aggregate Asset Value|IMA: Aggregate Company Assets|Shattuck Labs, Inc. (STTK) - Cumulative Company Assets|EQ - Cumulative Company Assets|Connect Biopharma Holdings Limited (CNTB) - Aggregate Business Assets|Company Total Assets IMUX|Cumulative Company Assets Atara Biotherapeutics Inc|Company Total Assets InflaRx N.V. (IFRX)|Aggregate Company Assets XFOR (x4pharma.com)|Adicet Bio, Inc. (ACET) - Aggregate Company Assets|Celularity Inc - Total Asset Value of Company|Aggregate Company Assets INmune Bio Corp|BRNS - Total Asset Value of Company|Company Total Assets Kezar Life Sciences KZR|sabbiotherapeutics.com (SABS) - Aggregate Asset Value|AKTX (Akari Therapeutics Plc) - Company Total Assets|Company Total Assets ENLV|Q32 Bio Inc. (QTTB) - Aggregate Company Assets|Aggregate Asset Value GOVX (GeoVax Corp)|Edesa Biotech, Inc. - Aggregate Company Assets|Cumulative Company Assets ibioinc.com IBIO|Carisma Tx - Company Total Assets|XTL Biopharmaceuticals Ltd (XTLB) - Company Total Assets|Cumulative Company Assets boltbio.com BOLT|HCW Biologics (HCWB) - Aggregate Asset Value|APVO: Company Total Assets|Company Total Asset Base AIM|Aggregate Company Assets ADTX (Aditxt)|Cumulative Company Assets GRI (GRI Bio Inc)|XORTX - Aggregate Company Assets|HIND - Cumulative Company Assets|Revelation Biosciences - Cumulative Company Assets|INDP: Company Total Assets|Aggregate Company Assets Scinai Immunotherapeutics Ltd.|CalciMedica (CALI) - Total Business Assets|Company Total Assets AFMD (Affimed NV)|Company Assets Allakos Therapeutics (ALLK)|Cumulative Company Assets HOOKIPA Pharma Inc.|Aggregate Business Assets igmbio.com (IGMS)|iTeos Therapeutics, Inc. - Company Total Assets|OCEA - Cumulative Company Assets|Cumulative Company Assets Third Harmonic Bio, Inc (THRD)